Table 3.
Change in normalised biopotential vs protein log fold change between cancerous and non-cancerous samples.
| Protein Probe | logFC | P Value | Adjusted P Value |
|---|---|---|---|
| CDK1 | 10.08 | 9.3E-05 | 0.028 |
| INPP4b | −2.08 | 6.7E-04 | 0.064 |
| FAK pY397 | −2.85 | 8.7E-04 | 0.064 |
| PKM2 | 9.05 | 1.1E-03 | 0.064 |
| EMA | 12.70 | 1.2E-03 | 0.064 |
| PAICS | 2.93 | 1.9E-03 | 0.064 |
| CD31 | −2.79 | 1.9E-03 | 0.064 |
| Bcl xL | 4.25 | 2.2E-03 | 0.064 |
| Bcl2 | −3.18 | 2.3E-03 | 0.064 |
| S6 pS235 S236 | 6.25 | 2.6E-03 | 0.064 |
Correlation statistics between changes in biopotential and protein expression between cancerous and non-cancerous samples, respectively (n = 10). The tumour cellularity difference between cancerous and non-cancerous samples are also included in this model. Linear regression analysis was performed to generate these statistics, including the log2 fold change (logFC) of the trend observed, the p-statistic and adjusted p-statistic. Top 10 most significant trends are shown, with CDK1 being the only statistically significant observation.